Growth and nutrition in children with ataxia telangiectasia

Background Ataxia telangiectasia (A-T) is a rare multisystem disease with high early mortality from lung disease and cancer. Nutritional failure adversely impacts outcomes in many respiratory diseases. Several factors influence nutrition in children with A-T. We hypothesised that children with A-T have progressive growth failure and that early gastrostomy tube feeding (percutaneous endoscopic gastrostomy, PEG) is a favourable management option with good nutritional outcomes. Methods Data were collected prospectively on weight, height and body mass index (BMI) at the national paediatric A-T clinic. Adequacy and safety of oral intake was assessed. Nutritional advice was given at each multidisciplinary review. Results 101 children (51 girls) had 222 measurements (32 once, 32 twice, 24 thrice) between 2009 and 2016. Median (IQR) age was 9.3 (6.4 to 13.1) years. Mean (SD) weight, height and BMI Z-scores were respectively −1 (1.6), −1.2 (1.2) and −0.4 (1.4). 35/101 children had weight Z-scores below −2 on at least one occasion. Weight, height and BMI Z-scores declined over time. Decline was most obvious after 8 years of age. 14/101 (14%) children had a PEG, with longitudinal data available for 12. In a nested case control study, there was a trend for improvement in weight in those with a PEG (p=0.10). Conclusions Patients with A-T decline in growth over time. There is an urgent need for new strategies, including an understanding of why growth falters. We suggest early proactive consideration of PEG from age 8 years onwards to prevent progressive growth failure.

[1]  B. Ben-Zeev,et al.  Ataxia telangiectasia. , 2015, Handbook of clinical neurology.

[2]  A. Bush,et al.  ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia , 2015, European Respiratory Review.

[3]  P. Robinson,et al.  Clinical audit results in earlier nutritional intervention in malnourished children with cystic fibrosis with improved outcome , 2015, Journal of paediatrics and child health.

[4]  M. Lavin,et al.  Nutritional status of patients with ataxia‐telangiectasia: A case for early and ongoing nutrition support and intervention , 2015, Journal of paediatrics and child health.

[5]  K. Kidwell,et al.  Improving nutritional status in a pediatric cystic fibrosis center , 2015, Pediatric pulmonology.

[6]  S. Tanumihardjo,et al.  Undernutrition, the acute phase response to infection, and its effects on micronutrient status indicators. , 2014, Advances in nutrition.

[7]  V. De Sanctis,et al.  Linear growth and endocrine function in children with ataxia telangiectasia , 2014, Indian journal of endocrinology and metabolism.

[8]  B. Costa-Carvalho,et al.  The relationship between nutritional status, vitamin A and zinc levels and oxidative stress in patients with ataxia-telangiectasia. , 2014, Allergologia et immunopathologia.

[9]  R. Schubert,et al.  Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia , 2014, Growth factors.

[10]  T. Crawford,et al.  Pulmonary function in children and young adults with ataxia telangiectasia , 2014, Pediatric pulmonology.

[11]  T. Crawford,et al.  Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia , 2011, Orphanet journal of rare diseases.

[12]  S. Mahant,et al.  Tube feeding and quality of life in children with severe neurological impairment , 2009, Archives of Disease in Childhood.

[13]  S. Mahant,et al.  Enterostomy tube placement in children with spinal muscular atrophy type 1. , 2006, The Journal of pediatrics.

[14]  T. Crawford,et al.  Survival probability in ataxia telangiectasia , 2005, Archives of Disease in Childhood.

[15]  R. Schubert,et al.  Growth factor deficiency in patients with ataxia telangiectasia , 2005, Clinical and experimental immunology.

[16]  J. Casanova,et al.  Primary immunodeficiency diseases: an update. , 2004, The Journal of allergy and clinical immunology.

[17]  S. Anker,et al.  Wasting as an independent predictor of mortality in patients with cystic fibrosis , 2001, Thorax.

[18]  P. Glazer,et al.  ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Crawford,et al.  Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. , 2000, The Journal of pediatrics.

[20]  D. Gozal,et al.  Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. , 1998, Journal of pediatric gastroenterology and nutrition.

[21]  A. Kessling,et al.  9 Diabetes secondary to genetic disorders , 1992 .

[22]  A. Taylor,et al.  Unusual features in the inheritance of ataxia telangiectasia , 1990, Human Genetics.

[23]  L. Kupper,et al.  Diabetes Mellitus in Ataxia-Telangiectasia, Fanconi Anemia, Xeroderma Pigmentosum, Common Variable Immune Deficiency, and Severe Combined Immune Deficiency Families , 1986, Diabetes.

[24]  M. Rechler,et al.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. , 1978, The New England journal of medicine.

[25]  D. McFarlin,et al.  An unusual form of diabetes mellitus in ataxia telangiectasia. , 1970, The New England journal of medicine.

[26]  J. Girardet,et al.  Nutrition and severe chronic respiratory diseases: Pathophysiologic mechanisms , 2001, Pediatric pulmonology.

[27]  A. Kessling,et al.  Diabetes secondary to genetic disorders. , 1992, Bailliere's clinical endocrinology and metabolism.

[28]  M. Corey,et al.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. , 1988, Journal of clinical epidemiology.